(4-Bromophenyl)(piperidin-4-yl)methanone
95%
- Product Code: 82068
CAS:
746550-66-3
| Molecular Weight: | 268.15 g./mol | Molecular Formula: | C₁₂H₁₄BrNO |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD04114992 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, airtight |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting the central nervous system. Researchers often employ it in the development of potential therapeutic agents, such as receptor modulators or enzyme inhibitors, due to its structural features that allow for interaction with specific biological targets. Its piperidine moiety and aromatic bromine substitution make it a versatile building block for designing compounds with potential antipsychotic, analgesic, or anti-inflammatory properties. Additionally, it is used in the study of structure-activity relationships (SAR) to optimize drug candidates for improved efficacy and reduced side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿4,464.00 |
+
-
|
(4-Bromophenyl)(piperidin-4-yl)methanone
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting the central nervous system. Researchers often employ it in the development of potential therapeutic agents, such as receptor modulators or enzyme inhibitors, due to its structural features that allow for interaction with specific biological targets. Its piperidine moiety and aromatic bromine substitution make it a versatile building block for designing compounds with potential antipsychotic, analgesic, or anti-inflammatory properties. Additionally, it is used in the study of structure-activity relationships (SAR) to optimize drug candidates for improved efficacy and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :